Under 21 CFR Part 312, a Phase 2 clinical investigation is primarily intended to accomplish which objective?
-
A
Establish maximum tolerated dose in healthy volunteers
-
B
Evaluate effectiveness and identify common short-term side effects
-
C
Confirm efficacy in large multicenter trials
-
D
Conduct post-approval safety studies